Drugs / Recombinant-human interferon beta-1a
Recombinant-human interferon beta-1a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00367484 | May 2004 → Jan 2006 | relapsing-remitting multiple sclerosis | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant-human interferon beta-1a | “Recombinant-human interferon beta-1a” NCT00367484 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant-human interferon beta-1a” NCT00367484 ↗ |